Signature combinatorial splicing profiles of rat cardiac- and smooth-muscle Cav1.2 channels with distinct biophysical properties
Introduction
The Cav1.2 l-type voltage-gated calcium channels play critical roles in membrane excitability, gene expression, cardiac- and smooth-muscle contraction [1], [2], [3], [4]. The Cav1.2 channel is a complex of three distinct subunits, the pore-forming α1 (or Cav1.2) subunit and an intracellular β subunit and a transmembrane disulfide-linked α2δ subunit [5]. The Cav1.2 subunit of ∼240 kDa is the largest subunit and it incorporates the conduction pore, the voltage sensor and gating apparatus and sites for channel regulation by second messengers, drugs and toxins [6], [7]. Interestingly, the Cav1.2 subunit is subjected to extensive alternative splicing and generates many isoforms with distinct functional diversity. There are 10 among the 52 known rat Cav1.2 exons that undergo alternative splicing [8], [9], [10], [11], [12], [13]. These exons are the mutually exclusive exons 1/1a, 8/8a, 21/22, 31/32 and the alternate exons 9* and 33 (Fig. 1). In this study, we identified another alternate exon 32-6nt which is generated by splicing at alternate donor site of exon 32 resulting in the deletion of last six nucleotides, while the human counterpart of this splice variation has been identified [14], [15]. Previous studies have shown that exon 1a is subjected to protein kinase C regulation [13], [16], [17], exon 8/8a and exon 21/22 confer different pharmacology to channels [18], [19], [20] and Cav1.2 subunits containing exon 9* or exon 33 alter channel gating properties [15], [21].
Theoretically, these 11 alternatively spliced exons might generate a large number of, i.e. 2 × 3 × 27 = 768 different exon-combinations of Cav1.2 transcripts. Here, the estimated number is calculated according to the proposition that there are two alternative initial exon 1a and exon 1 (also referred to as exon 1b) driven by the two distinct promoters [22], [23], [24], three alternative options of exon 32, exon 32-6nt or (-exon 32) and the other seven alternatively spliced exons 8a, 8, 9*, 21, 22, 31 and 33. It is noteworthy that the putative mutually exclusive exons 8a/8, 21/22, 31/32 are not strictly mutually exclusive as shown in this study and in previous reports [14], [15]. Due to such complexity, the real combinations of alternatively spliced exons of Cav1.2 gene in native tissues have not been solved, leaving a critical gap in knowledge in the Cav1.2 channel field. Therefore, the existence of these 11 alternatively spliced exons poses challenging questions: (1) Are the combinatorial arrangements of the alternatively spliced exons random or linked? (2) If linked, how many combinatorial splicing profiles are there in muscle tissues? And (3) are there tissue-specificity in the expression of the Cav1.2 splicing profiles?
This study attempts to provide answers to these questions by generating three full-length Cav1.2 cDNA libraries: one specific to aorta smooth muscle and two heart muscle libraries containing either exon 1 or exon 1a, the alternative initial exons. To circumvent the limitation of traditional cDNA library screening in which the desired cDNA clones are generally fragmented and are presented in very limited copy numbers, we employed long RT-PCR method to generate 284 full-length Cav1.2 cDNA clones in the three libraries. The utilization of alternatively spliced exons was examined by PCR colony screening in 96-well format for each of the 11 exons. Our results showed a complexity in combinatorial splicing profiles that surpassed what is known of two previously reported Cav1.2 splice variants, namely the “cardiac form” α1C-a (1a, 8a, −9*, 31) and “smooth muscle form” α1C-b (1, 8, 9*, 32) [6], [19], [25], [26], [27], [28]. Our study found 41 full-length Cav1.2 transcripts in heart and aortic tissues of Wistar Kyoto (WKY) rats with a few signature splicing profiles to describe cardiac- or smooth-muscle Cav1.2 channels. Our data also indicated that expression of alternatively spliced exons are linked and some individual exons have tissue-specific expression, while in combination, distinct splicing profiles can be identified in cardiac- and smooth-muscles. These various Cav1.2 combinatorial splice variants exhibited phenotypic variations of electrophysiological properties which as a whole support the importance of alternative splicing in generating channel functional diversity in muscle.
Section snippets
Total RNA extraction and reverse transcription for first strand cDNA synthesis of rat Cav1.2 gene
All animal work has been approved by and done in accordance with the Institutional Animal Care And Use Committee (IACUC) guidelines of the National University of Singapore. Three male and two female 14–18 weeks old Wistar Kyoto (WKY) rats (Canning Vale, WA 6970, Australia) were euthanized by CO2 and then heart and aortic tissues were quickly collected and stored in RNAlater reagent. Total RNA was extracted from ventricular and aortic tissues of five WKY rats by RNeasy® Kits (QIAGEN Science,
Distribution of exon 1a and exon 1 in heart and aorta and generation of full-length rat Cav1.2 cDNAs
Similar to the previous studies in human Cav1.2 transcripts [15], [22], exon 1a was found to be expressed specifically in rodent heart, while exon 1 was expressed in both rat heart and aorta (Fig. 2A.). As such, RT-PCR reactions were carried out to amplify full-length amplicons containing exon 1a-50 and exon 1–50 from rat ventricular muscle mRNA, but cDNA library of only exon 1–50 amplicons was generated from rat aorta (Fig. 2B and C). The PCR products from 5 individual WKY rats with similar
Discussion
In this report, we have provided answers to the three questions posed: (1) there are linkages in the utilization of alternatively spliced exons in Cav1.2 channels; (2) the number of combinatorial splicing profiles obtained are 41 and (3) there is tissue-specificity in the expression of combinatorial splicing profiles in cardiac- and smooth-muscle Cav1.2 channels. But notably, there is absence of a single muscle-type specific Cav1.2 splice isoform. Instead, the Cav1.2 splice variants in heart
Acknowledgements
We thank Guang Li, Dr Ping Liao and Tan Fong Yong for excellent technical support and discussion and Gregory Tan and Mui Cheng Liang for help in preparing the manuscript. This work was supported by grants from the Singapore Biomedical Research Council and the National Medical Research Council (TWS).
References (51)
- et al.
Nomenclature of voltage-gated calcium channels
Neuron
(2000) - et al.
Distinct calcium channels are generated by alternative splicing and are differentially expressed in the mammalian CNS
Neuron
(1991) - et al.
cDNA cloning of a dihydropyridine-sensitive calcium channel from rat aorta. Evidence for the existence of alternatively spliced forms
J. Biol. Chem.
(1990) - et al.
Molecular diversity of l-type calcium channels. Evidence for alternative splicing of the transcripts of three non-allelic genes
J. Biol. Chem.
(1990) Molecular diversity of voltage-sensitive calcium channels in smooth muscle cells
J. Lab. Clin. Med.
(1999)- et al.
The N terminus of the cardiac l-type Ca(2+) channel alpha(1C) subunit. The initial segment is ubiquitous and crucial for protein kinase C modulation, but is not directly phosphorylated
J. Biol. Chem.
(1999) - et al.
l-type Ca2+ channel alpha 1c subunit isoform switching in failing human ventricular myocardium
J. Mol. Cell. Cardiol.
(2000) - et al.
Transcript scanning reveals novel and extensive splice variations in human l-type voltage-gated calcium channel, Cav1.2 alpha1 subunit
J. Biol. Chem.
(2004) - et al.
Different voltage-dependent inhibition by dihydropyridines of human Ca2+ channel splice variants
J. Biol. Chem.
(1995) - et al.
Ca2+ channel sensitivity towards the blocker isradipine is affected by alternative splicing of the human alpha1C subunit gene
FEBS Lett.
(1998)
Smooth muscle-selective alternatively spliced exon generates functional variation in Cav1.2 calcium channels
J. Biol. Chem.
Tissue-specific expression of two human Ca(v)1.2 isoforms under the control of distinct 5′ flanking regulatory elements
FEBS Lett.
Expression of multiple Cav1.2 transcripts in rat tissues mediated by different promoters
Cell Calcium
Smooth muscle uses another promoter to express primarily a form of human Cav1.2 l-type calcium channel different from the principal heart form
Biochem. Biophys. Res. Commun.
Primary structure and functional expression of a high voltage activated calcium channel from rabbit lung
FEBS Lett.
Promoter choice determines splice site selection in protocadherin alpha and gamma pre-mRNA splicing
Mol. Cell.
Genomic structure of human l-type Ca2+ channel
Genomics
Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism
Cell
Cell-specific alternative splicing increases calcium channel current density in the pain pathway
Neuron
Voltage-gated calcium channels
Cardiac excitation-contraction coupling
Nature
Coupling of Ca(2+) to CREB activation and gene expression in intact cerebral arteries from mouse: roles of ryanodine receptors and voltage-dependent Ca(2+) channels
Circ. Res.
Isoform-specific regulation of mood behavior and pancreatic beta cell and cardiovascular function by l-type Ca2+ channels
J. Clin. Invest.
Structure and regulation of voltage-gated Ca2+ channels
Annu. Rev. Cell Dev. Biol.
The l-type calcium channel in the heart: the beat goes on
J. Clin. Invest.
Cited by (44)
Vascular Ca<inf>V</inf>1.2 channels in diabetes
2022, Current Topics in MembranesCitation Excerpt :Cardiac myocytes and vascular smooth muscle are termed CaV1.2a and CaV1.2b, respectively (Liao & Soong, 2010). The smooth muscle isoform of CaV1.2 is different from the cardiac counterpart in several regions, including mutually exclusive exons 1a/1b in the NH2 terminal, at the first homologous domain (IS6), which is coded by mutually exclusive exon 8a in the heart, and exon 8 in smooth muscle, and at the S3 of the fourth homologous domain (IVS3), which contains exon 31 or 32 in the cardiac and smooth muscle CaV1.2, respectively (Liao et al., 2005; Tang, Hong, Wang, & Soong, 2007; Yeow, Loh, & Soong, 2021). The smooth muscle CaV1.2b isoform also contains exon 9*, an insertion of 25 amino acid residues at the cytosolic loop between homologous domains I and II (Cheng et al., 2009; Liao et al., 2005, 2007) (Fig. 1).
Alternative Splicing at N Terminus and Domain I Modulates Ca<inf>V</inf>1.2 Inactivation and Surface Expression
2018, Biophysical JournalCitation Excerpt :The N-terminal exon 1 can be alternatively spliced by utilizing alternative 5′ promoters to produce exon 1a, which is predominantly expressed in cardiac muscle cells; exon 1, which is predominantly expressed in smooth muscle cells; or exon 1c, which is highly expressed in resistance and cerebral arteries (26,31,32,41). We and others have elucidated the presence of multiple splice variants in rats and rabbits, and these variants showed distinct electrophysiological and pharmacological properties and modulatory sites (19,20,24,42,43). Notably, exon 1c is mainly expressed in arterial myocytes and to a lesser extent in cardiac myocytes (31).
Ca<inf>V</inf>1.2 channel N-terminal splice variants modulate functional surface expression in resistance size artery smooth muscle cells
2011, Journal of Biological ChemistryCitation Excerpt :Splicing of the CaV1.2 gene in arterial smooth muscle cells of resistance size arteries is more conservative and restricted to three mutually exclusive (exons 1b/c, 21/22, and 31/32) and two alternate (exons 9* and 33) exons (15, 16). Such splice variation can lead to modifications in recombinant channel voltage dependence and membrane insertion by auxiliary subunits (15, 16, 18, 20). Previous studies detected CaV1.2 exon 1b and 1c mRNA in cardiac and cerebral artery smooth muscle cells (15).
Calcium and activity-dependent signaling in the developing cerebral cortex
2022, Development (Cambridge)